Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Total Current Assets
Meridian Bioscience Inc
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Total Current Assets
$210.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Total Current Assets
$1.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Total Current Assets
$1.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Current Assets
$2.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Current Assets
$1.1B
|
CAGR 3-Years
90%
|
CAGR 5-Years
43%
|
CAGR 10-Years
30%
|
See Also
What is Meridian Bioscience Inc's Total Current Assets?
Total Current Assets
210.6m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Total Current Assets amounts to 210.6m USD.
What is Meridian Bioscience Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
9%
Over the last year, the Total Current Assets growth was 9%. The average annual Total Current Assets growth rates for Meridian Bioscience Inc have been 13% over the past three years , 9% over the past five years .